Today, marks World Autism Day. Dr. Adi Aran, the Head of our Larry & Leonore Zussman Pediatric Neurology Unit, has launched a study that is receiving worldwide attention testing the effects of cannabinoids on 120 autistic children and young adults.

Autism is a neuro-developmental disorder, which occurs in roughly one out of every 100 births in Israel and is four times more prevalent among males. Symptoms become noticeable, typically, by age three and affects the person’s ability to communicate, to develop relationships with other people and to interact and respond to the world around them.

Dr. Aran’s study tests the effect of cannabis oils rich in cannabidiol (CBD), an active chemical found in cannabis but with low levels of tetrahydrocannabinol (THC) which is the chemical responsible for many of marijuana’s psychological effects. Dr. Aran said, “Our waiting lists are full. Many, many families want to participate and they come from all over Israel…They hope and they heard from their friends and other families that it might help.”

Please read this article that was recently published for more information.
#LIUB

http://www.timesofisrael.com/in-pioneering-study-israeli-researchers-target-autism-with-cannabis/